Jump to main content
Jump to site search

Issue 1, 2014
Previous Article Next Article

Technologies for detection of circulating tumor cells: facts and vision

Author affiliations

Abstract

Hematogeneous tumor cell dissemination is a key step in cancer progression. The detection of CTCs in the peripheral blood of patients with solid epithelial tumors (e.g., breast, prostate, lung and colon cancer) holds great promise, and many exciting technologies have been developed over the past years. However, the detection and molecular characterization of circulating tumor cells (CTCs) remain technically challenging. The identification and characterization of CTCs require extremely sensitive and specific analytical methods, which are usually a combination of complex enrichment and detection procedures. CTCs occur at very low concentrations of one tumor cell in the background of millions of normal blood cells and the epithelial–mesenchymal plasticity of CTCs can hamper their detection by the epithelial markers used in current CTC assays. In the present review, we summarize current methods for the enrichment and detection of CTCs and discuss the key challenges and perspectives of CTC analyses within the context of improved clinical management of cancer patients.

Graphical abstract: Technologies for detection of circulating tumor cells: facts and vision

Back to tab navigation

Publication details

The article was received on 28 May 2013, accepted on 23 Sep 2013 and first published on 23 Sep 2013


Article type: Critical Review
DOI: 10.1039/C3LC50644D
Citation: Lab Chip, 2014,14, 57-62
  •   Request permissions

    Technologies for detection of circulating tumor cells: facts and vision

    C. Alix-Panabières and K. Pantel, Lab Chip, 2014, 14, 57
    DOI: 10.1039/C3LC50644D

Search articles by author

Spotlight

Advertisements